Opioids Flashcards
Ascending pain pathway
starts from terminals of primary afferent neuron fibers
A delta: fast conducting
C: slow conducting
descending pain pathway exerts inhibitory effect on pain transmission through _____
substantia gelatinosa
the pain-inhibitory neuron is indirectly activated by _____
opioids (exogenous or endogenous)
which inhibit an inhibitory GABAergic interneuron results in enhanced inhibition of nociceptive processing
what is the mechanism of the opioid receptor transducer
agonist binds
conformational changes in GPCR
inhibits adenylyl cyclase
stimulates K+ current
inhibits voltage gated Ca2+ channels
decreased release of neurotransmitters
describe the relationship between pain & endogenous/exogenous opioids
pain is modulated by endogenous opioid peptides
exogenous opioids are effective analgesics
many drugs of abuse act on endogenous opioid system
definition of opioids
molecules that interact with opioid receptors; compounds with morphine-like activity
diff opioid compounds?
opioid receptor agonists, antagonists, modulators
what are phenanthrene derivatives
morphine (10% in opium)
codeine (0.5% in opium)
thebaine (0.2% in opium, nonanalgesic)
what are the natural opium, semisynthetic, and synthetic opioids?
natural opium alkaloids: morphine, codeine
semisynthetic: heroin (diacetylmorphine), pholcodine
synthetic: pethidine (meperidine), fentanyl, sufentanil, alfentanil , remifentanil
opioid classes and their receptor type
endorphins: mu
enkephalins: delta
dynorphins: kappa
mu, delta, and kappa receptors are all ____
members of the G-protein coupled family of receptors
both ___ and ___ ligands bind to mu, delta, and kappa receptors
endogenous & exogenous
major opioid receptors are coupled to G proteins which causes what effects
affects ion channel gating
modulates intracellular Ca2+ disposition
alters protein phosphorylation
what are the two well-established direct G protein-coupled actions on neurons
closure of voltage-gated Ca2+ channels
opening of K+ channels
morphine’s prescription forms
and which form is the least potent
injectable, oral solution/tablets/capsules, suppositories
less potent orally due to extensive first-pass metabolism: 20-40% bioavailability